Product Information
GS MUCUS ER 600 MG CAPLET is a generic product labeled by L. Perrigo Company, priced at $0.2840 per EA under NDC 00113202360. Its NADAC has been published 176 times since May 24, 2023.
FDA first approved this application on Nov 23, 2011.
Strength
600 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113202360
Classification
Generic
Dosage Form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA078912FDA Approved
11/23/2011
On Market Since
7/4/2020
Pharmacological Classes
Price Statistics
The NADAC for GS MUCUS ER 600 MG CAPLET has been published 176 times since May 24, 2023, and over the history we have for it it has declined 16.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2840 per EA |
|---|---|
| All-time high | $0.3993 (Dec 11, 2024) |
| All-time low | $0.2812 (Oct 18, 2023) |
| 52-week high | $0.3211 |
| 52-week low | $0.2840 |
| Median price | $0.3209 |
| Average price | $0.3217 |
| Largest weekly change | +24.7% (Nov 20, 2024) |
| Weeks tracked | 176 |
| Tracking since | May 24, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS MUCUS ER 600 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for GS MUCUS ER 600 MG CAPLET, manufactured by L. Perrigo Company, is $0.2840 per EA (NDC 00113202360), effective Sep 30, 2026.
How has the price of GS MUCUS ER 600 MG CAPLET changed over time?
Over the history we have for it, the NADAC for GS MUCUS ER 600 MG CAPLET has declined 16.0%. It has been tracked across 176 weekly CMS publications since May 24, 2023.
What are the highest and lowest recorded NADAC prices for GS MUCUS ER 600 MG CAPLET?
Since May 24, 2023, the NADAC for GS MUCUS ER 600 MG CAPLET has ranged from a low of $0.2812 (Oct 18, 2023) to a high of $0.3993 (Dec 11, 2024), with a median of $0.3209 per EA.
Are there cheaper alternatives to GS MUCUS ER 600 MG CAPLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GS MUCUS ER 600 MG CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GS MUCUS ER 600 MG CAPLET?
GS MUCUS ER 600 MG CAPLET (NDC 00113202360) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.